Mark A Watson Selected Research

Mark A Watson Research Topics

Disease

32	Neoplasms (Cancer) 01/2020 - 03/2002
12	Breast Neoplasms (Breast Cancer) 11/2019 - 02/2004
8	Colorectal Neoplasms (Colorectal Cancer) 10/2008 - 01/2003
6	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2003
4	Adenocarcinoma 01/2018 - 08/2008
3	Adenocarcinoma of Lung 03/2020 - 12/2007
3	Neurofibrosarcoma (MPNST) 04/2011 - 07/2004
2	Carcinoma (Carcinomatosis) 01/2019 - 06/2012
2	Brain Neoplasms (Brain Tumor) 01/2018 - 03/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2009 - 06/2009
2	Acute Promyelocytic Leukemia 06/2009 - 02/2007
2	Meningioma (Meningiomas) 08/2005 - 08/2002
2	Adenoma (Adenomas) 04/2005 - 03/2002
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Obesity 01/2020
1	Insulin Resistance 01/2020
1	Inflammation (Inflammations) 01/2020
1	Kidney Calculi (Kidney Stone) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Gout 01/2019
1	Disease Progression 01/2018
1	Atrophy 06/2012
1	Sarcoma (Soft Tissue Sarcoma) 04/2011
1	Acinar Cell Carcinoma 10/2009
1	Metaplasia 08/2009
1	Leukemia 06/2009
1	Genetic Translocation (Chromosomal Translocation) 06/2009
1	Heart Failure 03/2009
1	Cardiomyopathies (Cardiomyopathy) 03/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2008
1	Pain (Aches) 01/2008
1	Neoplasm Micrometastasis 09/2007

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
10	RNA (Ribonucleic Acid)IBA 03/2020 - 10/2002
8	Messenger RNA (mRNA)IBA 11/2020 - 02/2004
8	Biomarkers (Surrogate Marker)IBA 03/2020 - 08/2005
8	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 12/2007
4	Estrogen ReceptorsIBA 01/2018 - 05/2009
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2009
3	ErbB Receptors (EGF Receptor)IBA 10/2008 - 03/2006
3	OligonucleotidesIBA 03/2006 - 08/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 06/2006
2	LipidsIBA 01/2020 - 06/2006
2	AcidsIBA 01/2020 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 10/2015 - 12/2007
2	Complement System Proteins (Complement)IBA 09/2009 - 08/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2009 - 02/2004
2	Estrogens (Estrogen)FDA Link 05/2009 - 02/2004
2	A-Form DNA (A-DNA)IBA 10/2008 - 03/2002
2	ApolipoproteinsIBA 06/2006 - 05/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004 - 08/2002
1	Long Noncoding RNAIBA 03/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	9-hydroxy-10,12-octadecadienoic acidIBA 01/2020
1	Uric Acid (Urate)IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	LigandsIBA 01/2019
1	Estrogen Receptor alphaIBA 01/2018
1	CytoglobinIBA 06/2012
1	N(w)-nitroarginine benzyl ester (NABE)IBA 06/2012
1	Anastrozole (Arimidex)FDA LinkGeneric 06/2011
1	exemestane (Aromasin)FDA Link 06/2011
1	Letrozole (Femara)FDA LinkGeneric 06/2011
1	Phenobarbital (Luminal)FDA Link 06/2011
1	Aromatase InhibitorsIBA 06/2011
1	Forkhead Box Protein M1IBA 04/2011
1	Prolactin Receptors (Prolactin Receptor)IBA 10/2009
1	Keratin-5 (Keratin 5)IBA 08/2009
1	methionylmethionine (Met-Met)IBA 08/2009
1	Retinoic Acid Receptor alphaIBA 06/2009
1	dactolisibIBA 05/2009
1	MicroRNAs (MicroRNA)IBA 03/2009
1	Formaldehyde (Formol)FDA Link 10/2008
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2008
1	Thymidylate SynthaseIBA 10/2008
1	SmokeIBA 10/2008
1	ParaffinIBA 10/2008
1	64Cu-DOTA-cetuximabIBA 09/2008
1	Cetuximab (Erbitux)FDA Link 09/2008
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 09/2008
1	Celecoxib (Celebrex)FDA Link 08/2008
1	Pharmaceutical PreparationsIBA 08/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2008
1	salicylhydroxamic acid (SHAM)IBA 01/2008
1	Epithelial Cell Adhesion MoleculeIBA 09/2007

Therapy/Procedure

10	Therapeutics 11/2019 - 03/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 03/2005
3	Neoadjuvant Therapy 11/2019 - 09/2007
3	Lasers (Laser) 06/2012 - 01/2005
1	Immunotherapy 01/2019
1	Radiotherapy 01/2018
1	Aftercare (After-Treatment) 06/2011
1	Segmental Mastectomy (Lumpectomy) 06/2011
1	Heart-Assist Devices 03/2009